Trial Title:
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
NCT ID:
NCT05568095
Condition:
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Conditions: Official terms:
Adenocarcinoma
Leucovorin
Capecitabine
Fluorouracil
Nivolumab
Oxaliplatin
Conditions: Keywords:
Domvanalimab
Zimberelimab
Nivolumab
Advanced upper gastrointestinal tract adenocarcinoma
Gastroesophageal junction cancer
Esophageal adenocarcinoma
Gastric cancer
Gastric adenocarcinoma
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Drug
Intervention name:
Domvanalimab
Description:
Intravenous (IV) Aqueous Solution
Arm group label:
Domvanalimab + Zimberelimab + FOLFOX/CAPOX (PI Choice)
Other name:
AB154
Intervention type:
Drug
Intervention name:
Zimberelimab
Description:
IV Aqueous Solution
Arm group label:
Domvanalimab + Zimberelimab + FOLFOX/CAPOX (PI Choice)
Other name:
AB122
Intervention type:
Drug
Intervention name:
Capecitabine
Description:
Oral Tablets
Arm group label:
Domvanalimab + Zimberelimab + FOLFOX/CAPOX (PI Choice)
Arm group label:
Nivolumab + FOLFOX/CAPOX (PI Choice)
Intervention type:
Drug
Intervention name:
Fluorouracil
Description:
IV Aqueous Solution
Arm group label:
Domvanalimab + Zimberelimab + FOLFOX/CAPOX (PI Choice)
Arm group label:
Nivolumab + FOLFOX/CAPOX (PI Choice)
Intervention type:
Drug
Intervention name:
Leucovorin
Description:
IV Aqueous Solution
Arm group label:
Domvanalimab + Zimberelimab + FOLFOX/CAPOX (PI Choice)
Arm group label:
Nivolumab + FOLFOX/CAPOX (PI Choice)
Intervention type:
Drug
Intervention name:
Oxaliplatin
Description:
IV Aqueous Solution
Arm group label:
Domvanalimab + Zimberelimab + FOLFOX/CAPOX (PI Choice)
Arm group label:
Nivolumab + FOLFOX/CAPOX (PI Choice)
Intervention type:
Drug
Intervention name:
Nivolumab
Description:
IV Aqueous Solution
Arm group label:
Nivolumab + FOLFOX/CAPOX (PI Choice)
Summary:
This randomized Phase 3 open-label study will compare the efficacy of the T-cell
immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT)
monoclonal antibody domvanalimab, the anti programmed cell death protein 1 (PD-1)
monoclonal antibody zimberelimab, and multiagent chemotherapy versus the anti PD-1
monoclonal antibody nivolumab and multiagent chemotherapy in the first-line treatment of
participants with locally advanced unresectable or metastatic gastric, gastroesophageal
junction (GEJ), and esophageal adenocarcinoma.
Criteria for eligibility:
Criteria:
Key Inclusion Criteria:
- Capable of giving signed informed consent which is in compliance with the
requirements and restrictions listed in the informed consent form (ICF) and in
protocol.
- Histologically confirmed diagnosis of locally advanced unresectable or metastatic
gastric, GEJ, or esophageal adenocarcinoma.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
- At least one measurable target lesion per Response Evaluation Criteria in Solid
Tumors (RECIST) v1.1.
Key Exclusion Criteria:
- Underlying medical or psychiatric conditions that, in the investigator's or
sponsor's opinion, will make the administration of study-specified therapy
hazardous, including but not limited to:
- Interstitial lung disease, including history of interstitial lung disease or
non-infectious pneumonitis. Active viral, bacterial, or fungal infections requiring
parenteral treatment within 14 days of randomization.
- Clinically significant cardiovascular disease, such as New York Heart Association
Class II or greater cardiac disease or cerebrovascular accident within 3 months
prior to randomization, unstable angina, or new onset angina within 3 months prior
to randomization, myocardial infarction within 6 months prior to randomization, or
unstable arrhythmia within 3 months prior to randomization.
- History of prior solid-organ transplantation, including allogenic bone marrow
transplantation.
- Dementia, psychiatric, or substance abuse disorders that would interfere with
satisfying the requirements of the trial.
- Known human epidermal growth factor receptor 2 (HER-2) positive tumor.
- Known untreated, symptomatic, or actively progressing central nervous system (CNS)
(brain) metastases. Participants with leptomeningeal metastases are excluded from
enrollment.
- Received prior systemic treatment for locally advanced unresectable or metastatic
gastric, GEJ, or esophageal adenocarcinoma.
- Disease progression within 6 months of completion of neoadjuvant or adjuvant
therapy.
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Genesis Cancer Center and Blood Institute - Hot Springs
Address:
City:
Hot Springs
Zip:
71913
Country:
United States
Facility:
Name:
Kaiser Permanente - Los Angeles Medical Center
Address:
City:
Los Angeles
Zip:
90027
Country:
United States
Facility:
Name:
Norris Comprehensive Cancer Center
Address:
City:
Los Angeles
Zip:
90033
Country:
United States
Facility:
Name:
University of California Irvine Health Chao Family Comprehensive Cancer Center
Address:
City:
Orange
Zip:
92868
Country:
United States
Facility:
Name:
UCLA Health - Santa Monica Cancer Care
Address:
City:
Santa Monica
Zip:
90404
Country:
United States
Facility:
Name:
Yale Cancer Center
Address:
City:
New Haven
Zip:
06520
Country:
United States
Facility:
Name:
Georgetown Lombardi Comprehensive Cancer Center
Address:
City:
Washington
Zip:
22057
Country:
United States
Facility:
Name:
SCRI - Florida Cancer Specialists - South Region Research Office
Address:
City:
Fort Myers
Zip:
33901
Country:
United States
Facility:
Name:
SCRI - Florida Cancer Specialists - North Region Research Office
Address:
City:
Saint Petersburg
Zip:
33705
Country:
United States
Facility:
Name:
SCRI - Florida Cancer Specialists - Panhandle Research Office
Address:
City:
Tallahassee
Zip:
32308
Country:
United States
Facility:
Name:
SCRI - Florida Cancer Specialists - East Region Research Office
Address:
City:
West Palm Beach
Zip:
33401
Country:
United States
Facility:
Name:
University of Louisville James Graham Brown Cancer Center
Address:
City:
Louisville
Zip:
40202
Country:
United States
Facility:
Name:
Norton Cancer Institute - Poplar Level Road
Address:
City:
Louisville
Zip:
40217
Country:
United States
Facility:
Name:
Ochsner Cancer Institute
Address:
City:
New Orleans
Zip:
70121
Country:
United States
Facility:
Name:
Massachusetts General Hospital
Address:
City:
Boston
Zip:
02114
Country:
United States
Facility:
Name:
University of Michigan Rogel Cancer Center
Address:
City:
Ann Arbor
Zip:
48109
Country:
United States
Facility:
Name:
HealthPartners Cancer Center at Regions Hospital
Address:
City:
Saint Louis Park
Zip:
55426
Country:
United States
Facility:
Name:
Perlmutter Cancer Center - 38th Street
Address:
City:
New York
Zip:
10016
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Cancer Center - New York
Address:
City:
New York
Zip:
10065
Country:
United States
Facility:
Name:
Duke University Medical Center
Address:
City:
Durham
Zip:
27710
Country:
United States
Facility:
Name:
Cleveland Clinic - Taussig Cancer Center
Address:
City:
Cleveland
Zip:
44106
Country:
United States
Facility:
Name:
University Hospitals Cleveland Medical Center
Address:
City:
Cleveland
Zip:
44106
Country:
United States
Facility:
Name:
Providence Cancer Center Oncology and Hematology Care Westside Portland
Address:
City:
Portland
Zip:
97225
Country:
United States
Facility:
Name:
Prisma Health Cancer Institute - Faris Road
Address:
City:
Greenville
Zip:
29605
Country:
United States
Facility:
Name:
Tennessee Oncology - Chattanooga - Memorial Plaza
Address:
City:
Nashville
Zip:
37203
Country:
United States
Facility:
Name:
Tennessee Oncology - Nashville - Centennial
Address:
City:
Nashville
Zip:
37203
Country:
United States
Facility:
Name:
University of Texas Southwestern Medical Center
Address:
City:
Dallas
Zip:
75390
Country:
United States
Facility:
Name:
The Center for Cancer & Blood Disorders - Fort Worth
Address:
City:
Fort Worth
Zip:
76104
Country:
United States
Facility:
Name:
Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location
Address:
City:
Seattle
Zip:
98109
Country:
United States
Facility:
Name:
Froedtert Clinical Cancer Center
Address:
City:
Milwaukee
Zip:
53226
Country:
United States
Facility:
Name:
Hospital Británico de Buenos Aires
Address:
City:
Buenos Aires
Country:
Argentina
Facility:
Name:
CORI Centro Oncológico Riojano Integral
Address:
City:
La Rioja
Country:
Argentina
Facility:
Name:
Instituto de Investigaciones Clínicas Mar del Plata
Address:
City:
Mar del Plata
Country:
Argentina
Facility:
Name:
Monash University
Address:
City:
Clayton
Country:
Australia
Facility:
Name:
Gosford Hospital
Address:
City:
Gosford
Country:
Australia
Facility:
Name:
Liverpool Hospital
Address:
City:
Liverpool
Country:
Australia
Facility:
Name:
Oncology West - Murdoch
Address:
City:
Murdoch
Country:
Australia
Facility:
Name:
Fundação Pio XII - Hospital de Câncer de Barretos - Hospital de Amor
Address:
City:
Barretos
Country:
Brazil
Facility:
Name:
ONCOSITE - Centro de Pesquisa Clinica Em Oncologia Ltda.
Address:
City:
Ijuí
Country:
Brazil
Facility:
Name:
Liga Contra o Câncer - Centro Avançado de Oncologia
Address:
City:
Natal
Country:
Brazil
Facility:
Name:
Hospital Ernesto Dornelles
Address:
City:
Porto Alegre
Country:
Brazil
Facility:
Name:
Instituto Nacional de Câncer - Brazil
Address:
City:
Rio de Janeiro
Country:
Brazil
Facility:
Name:
Queen Elizabeth II Health Sciences Centre-Victoria General
Address:
City:
Halifax
Country:
Canada
Facility:
Name:
Hôpital Notre-Dame
Address:
City:
Montreal
Country:
Canada
Facility:
Name:
Ottawa Hospital - General Campus
Address:
City:
Ottawa
Country:
Canada
Facility:
Name:
Princess Margaret Cancer Centre
Address:
City:
Toronto
Country:
Canada
Facility:
Name:
Sunnybrook Health Sciences Centre - Bayview Campus
Address:
City:
Toronto
Country:
Canada
Facility:
Name:
Icegclinic
Address:
City:
La Florida
Country:
Chile
Facility:
Name:
Oncovida - Santiago
Address:
City:
Providencia
Country:
Chile
Facility:
Name:
Hospital Puerto Montt
Address:
City:
Puerto Montt
Country:
Chile
Facility:
Name:
Bradford Hill Centro de Investigaciones Clinicas
Address:
City:
Recoleta
Country:
Chile
Facility:
Name:
Centro de Estudios Clínicos SAGA
Address:
City:
Santiago
Country:
Chile
Facility:
Name:
Pontificia Universidad Catolica de Chile - Escuela De Medicina - Clinica UC San Carlos de Apoq
Address:
City:
Santiago
Country:
Chile
Facility:
Name:
Clínica Universidad Católica del Maule - Talca
Address:
City:
Talca
Country:
Chile
Facility:
Name:
AnYang Tumor Hospital
Address:
City:
Anyang
Country:
China
Facility:
Name:
The First People's Hospital of Changzhou
Address:
City:
Changzhou
Country:
China
Facility:
Name:
900 Hospital of The Joint Logistic Support Force of PLA
Address:
City:
Fuzhou
Country:
China
Facility:
Name:
Guangdong Provincial People's Hospital
Address:
City:
Guangzhou
Country:
China
Facility:
Name:
Sun Yat-Sen University Cancer Center
Address:
City:
Guangzhou
Country:
China
Facility:
Name:
Hainan General Hospital
Address:
City:
Haikou
Country:
China
Facility:
Name:
Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Address:
City:
Hangzhou
Country:
China
Facility:
Name:
Zhejiang Cancer Hospital
Address:
City:
Hangzhou
Country:
China
Facility:
Name:
Harbin Medical University Cancer Hospital
Address:
City:
Harbin
Country:
China
Facility:
Name:
Anhui Provincial Hospital
Address:
City:
Hefei
Country:
China
Facility:
Name:
The Second Hospital of Anhui Medical University
Address:
City:
Hefei
Country:
China
Facility:
Name:
The First Affiliated Hospital of Henan Science and Technology University
Address:
City:
Luoyang
Country:
China
Facility:
Name:
Shanghai East Hospital
Address:
City:
Shanghai
Country:
China
Facility:
Name:
Tianjin Medical University Cancer Institute & Hospital
Address:
City:
Tianjin
Country:
China
Facility:
Name:
Qinghai University Affiliated Hospital
Address:
City:
Xining
Country:
China
Facility:
Name:
Henan Cancer Hospital
Address:
City:
Zhengzhou
Country:
China
Facility:
Name:
Institut Bergonié
Address:
City:
Bordeaux cedex
Country:
France
Facility:
Name:
Hôpital Morvan
Address:
City:
Brest
Country:
France
Facility:
Name:
Centre de Lutte contre le Cancer - François Baclesse
Address:
City:
Caen Cedex 5
Country:
France
Facility:
Name:
Hôpital Claude Huriez
Address:
City:
Lille Cedex
Country:
France
Facility:
Name:
Centre Léon Bérard
Address:
City:
Lyon
Country:
France
Facility:
Name:
Hôpital de la Timone
Address:
City:
Marseille
Country:
France
Facility:
Name:
Institut Régional du Cancer de Montpellier
Address:
City:
Montpellier
Country:
France
Facility:
Name:
Centre Armoricain de Radiothérapie, d'Imagerie Médicale et d'Oncologie
Address:
City:
Plerin
Country:
France
Facility:
Name:
Centre Hospitalier Universitaire de Poitiers
Address:
City:
Poitiers
Country:
France
Facility:
Name:
Institut Gustave Roussy
Address:
City:
Villejuif
Country:
France
Facility:
Name:
Evex Hospitals - Kutaisi Referral Hospital
Address:
City:
Kutaisi
Zip:
4600
Country:
Georgia
Facility:
Name:
LLC Todua Clinic
Address:
City:
Tbilisi
Zip:
0112
Country:
Georgia
Facility:
Name:
Ltd Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
Address:
City:
Tbilisi
Zip:
0144
Country:
Georgia
Facility:
Name:
New Vision University Hospital
Address:
City:
Tbilisi
Zip:
0159
Country:
Georgia
Facility:
Name:
Multi-profile Clinic "New Hospitals"
Address:
City:
Tbilisi
Zip:
0186
Country:
Georgia
Facility:
Name:
Evgenidion Clinic SA - Agia Trias
Address:
City:
Athens
Country:
Greece
Facility:
Name:
General Oncology Hospital of Kifisias "Agioi Anargyroi"
Address:
City:
Nea Kifisia
Country:
Greece
Facility:
Name:
Metropolitan Hospital
Address:
City:
Neo Faliro
Country:
Greece
Facility:
Name:
Medi-k Cayalá
Address:
City:
Guatemala city
Country:
Guatemala
Facility:
Name:
Clínica Privada Dr. Rixci Ramírez
Address:
City:
Guatemala
Country:
Guatemala
Facility:
Name:
Grupo Medico Angeles
Address:
City:
Guatemala
Country:
Guatemala
Facility:
Name:
INTEGRA Cancer Institute
Address:
City:
Guatemala
Country:
Guatemala
Facility:
Name:
Centro Regional de Sub Especialidades Médicas (CRESEM) SA
Address:
City:
Quetzaltenango
Country:
Guatemala
Facility:
Name:
Hong Kong Sanatorium and Hospital
Address:
City:
Happy Valley
Country:
Hong Kong
Facility:
Name:
Humanity & Health Clinical Trial Centre
Address:
City:
Hong Kong
Country:
Hong Kong
Facility:
Name:
Tuen Mun Hospital
Address:
City:
Tuen Mun
Country:
Hong Kong
Facility:
Name:
Pécsi Tudományegyetem Klinikai Központ
Address:
City:
Pecs
Country:
Hungary
Facility:
Name:
Davidoff Cancer Center
Address:
City:
Petah Tikva
Country:
Israel
Facility:
Name:
Tel Aviv Sourasky Medical Center
Address:
City:
Tel Aviv
Country:
Israel
Facility:
Name:
Azienda Ospedaliero - Universitaria Careggi
Address:
City:
Firenze
Country:
Italy
Facility:
Name:
Istituto Europeo di Oncologia
Address:
City:
Milano
Country:
Italy
Facility:
Name:
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele
Address:
City:
Milan
Country:
Italy
Facility:
Name:
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Istituto Clinico Humanitas
Address:
City:
Rozzano
Country:
Italy
Facility:
Name:
Azienda Sanitaria Universitaria Friuli Centrale ? P.O. Santa Maria della Misericordia
Address:
City:
Udine
Country:
Italy
Facility:
Name:
Hyogo Cancer Center
Address:
City:
Akashi City
Country:
Japan
Facility:
Name:
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Address:
City:
Bunkyo-ku
Country:
Japan
Facility:
Name:
University of Tokyo Hospital
Address:
City:
Bunkyo-ku
Country:
Japan
Facility:
Name:
Chiba Cancer Center
Address:
City:
Chiba
Country:
Japan
Facility:
Name:
Kyushu Cancer Center
Address:
City:
Fukuoka-shi
Country:
Japan
Facility:
Name:
National Cancer Center - Kashiwa Campus
Address:
City:
Kashiwa
Country:
Japan
Facility:
Name:
St. Marianna University Hospital
Address:
City:
Kawasaki-Shi
Country:
Japan
Facility:
Name:
Cancer Institute Hospital of JFCR
Address:
City:
Koto
Country:
Japan
Facility:
Name:
Kumamoto University Hospital
Address:
City:
Kumamoto
Country:
Japan
Facility:
Name:
Shikoku Cancer Center
Address:
City:
Matsuyama-Shi
Country:
Japan
Facility:
Name:
Shizuoka Cancer Center
Address:
City:
Nagaizumi
Country:
Japan
Facility:
Name:
Aichi Cancer Center
Address:
City:
Nagoya
Country:
Japan
Facility:
Name:
Niigata Cancer Center Hospital
Address:
City:
Niigata
Country:
Japan
Facility:
Name:
Kindai University Hospital
Address:
City:
Osaka
Country:
Japan
Facility:
Name:
Osaka Prefectural Hospital Organization - Osaka International Cancer Institute
Address:
City:
Osaka
Country:
Japan
Facility:
Name:
Gunma Prefectural Cancer Center
Address:
City:
Ota-Shi
Country:
Japan
Facility:
Name:
Saitama Cancer Center
Address:
City:
Saitama
Country:
Japan
Facility:
Name:
National Cancer Center Hospital
Address:
City:
Tokyo
Country:
Japan
Facility:
Name:
Kanagawa Cancer Center
Address:
City:
Yokohama-shi
Country:
Japan
Facility:
Name:
Dong-A University Hospital
Address:
City:
Busan
Country:
Korea, Republic of
Facility:
Name:
Kyungpook National University Chilgok Hospital
Address:
City:
Daegu
Country:
Korea, Republic of
Facility:
Name:
Cha Bundang Medical Center
Address:
City:
Seongnam-si
Country:
Korea, Republic of
Facility:
Name:
Asan Medical Center
Address:
City:
Seoul
Country:
Korea, Republic of
Facility:
Name:
Korea University Guro Hospital
Address:
City:
Seoul
Country:
Korea, Republic of
Facility:
Name:
Samsung Medical Center
Address:
City:
Seoul
Country:
Korea, Republic of
Facility:
Name:
Seoul National University Hospital
Address:
City:
Seoul
Country:
Korea, Republic of
Facility:
Name:
Severance Hospital
Address:
City:
Seoul
Country:
Korea, Republic of
Facility:
Name:
Kauno Klinikos
Address:
City:
Kaunas
Country:
Lithuania
Facility:
Name:
Klaipedos Universitetine Ligonine
Address:
City:
Klaipeda
Country:
Lithuania
Facility:
Name:
Nacionalinis Vėžio Institutas
Address:
City:
Vilnius
Country:
Lithuania
Facility:
Name:
Vilniaus Universiteto Ligoninė Santariškių Klinikos
Address:
City:
Vilnius
Country:
Lithuania
Facility:
Name:
Hospital Pulau Pinang
Address:
City:
George Town
Country:
Malaysia
Facility:
Name:
Hospital Kuala Lumpur
Address:
City:
Kuala Lumpur
Country:
Malaysia
Facility:
Name:
Pusat Perubatan Universiti Malaya
Address:
City:
Kuala Lumpur
Country:
Malaysia
Facility:
Name:
Hospital Umum Sarawak
Address:
City:
Kuching
Country:
Malaysia
Facility:
Name:
CLIMERS Clinical Medical Research
Address:
City:
Colonia Centro
Zip:
94300
Country:
Mexico
Facility:
Name:
Centro de Atención e Investigación Clínica en Oncología
Address:
City:
Merida
Zip:
97134
Country:
Mexico
Facility:
Name:
Centro Especializado en Investigacion y Tratamiento Oncologicos SC
Address:
City:
Mexico DF
Zip:
3100
Country:
Mexico
Facility:
Name:
Hospital Zambrano Hellion TecSalud
Address:
City:
San Pedro Garza García
Zip:
66278
Country:
Mexico
Facility:
Name:
Centro Hemato - Oncológico Privado (CHOP)
Address:
City:
Toluca de Lerdo
Zip:
50120
Country:
Mexico
Facility:
Name:
Hospital Maria Auxiliadora
Address:
City:
San Juan De Miraflores
Country:
Peru
Facility:
Name:
Instituto Nacional de Enfermedades Neoplásicas
Address:
City:
Surquillo
Country:
Peru
Facility:
Name:
Dr Pablo O. Torre Memorial Hospital - Riverside Medical Center
Address:
City:
Bacolod City
Country:
Philippines
Facility:
Name:
Baguio General Hospital and Medical Center
Address:
City:
Baguio
Country:
Philippines
Facility:
Name:
Cebu Doctors' University Hospital
Address:
City:
Cebu City
Country:
Philippines
Facility:
Name:
Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli
Address:
City:
Lublin
Country:
Poland
Facility:
Name:
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy
Address:
City:
Warszawa
Country:
Poland
Facility:
Name:
Centro Hospitalar e Universitário de Coimbra
Address:
City:
Coimbra
Country:
Portugal
Facility:
Name:
Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud
Address:
City:
Lisboa
Country:
Portugal
Facility:
Name:
Instituto Português de Oncologia do Porto Francisco Gentil
Address:
City:
Porto
Country:
Portugal
Facility:
Name:
Spitalul Judetean de Urgenta
Address:
City:
Baia Mare
Country:
Romania
Facility:
Name:
Institutul Clinic Fundeni
Address:
City:
Bucharest
Country:
Romania
Facility:
Name:
Institutul Oncologic Prof. Dr. Ion Chiricuta
Address:
City:
Cluj-Napoca
Country:
Romania
Facility:
Name:
Medisprof
Address:
City:
Cluj-Napoca
Country:
Romania
Facility:
Name:
Centrul De Oncologie Sf Nectarie
Address:
City:
Craiova
Country:
Romania
Facility:
Name:
Centrul de Radioterapie Amethyst Cluj
Address:
City:
Florești
Country:
Romania
Facility:
Name:
Centrul de Oncologie Euroclinic
Address:
City:
Iasi
Country:
Romania
Facility:
Name:
Clinica SIGMedical
Address:
City:
Suceava
Country:
Romania
Facility:
Name:
University Hospital Medical Center (KBC) Bezanijska Kosa
Address:
City:
Belgrade
Country:
Serbia
Facility:
Name:
Clinical Center Kragujevac
Address:
City:
Kragujevac
Country:
Serbia
Facility:
Name:
Hospital Universitari Vall d'Hebrón
Address:
City:
Barcelona
Country:
Spain
Facility:
Name:
Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet)
Address:
City:
Barcelona
Country:
Spain
Facility:
Name:
Hospital General Universitario Gregorio Marañón
Address:
City:
Madrid
Country:
Spain
Facility:
Name:
Hospital Universitario HM Sanchinarro
Address:
City:
Madrid
Country:
Spain
Facility:
Name:
Hospital Universitario Ramón y Cajal
Address:
City:
Madrid
Country:
Spain
Facility:
Name:
Hospital Universitario Marqués de Valdecilla
Address:
City:
Santander
Country:
Spain
Facility:
Name:
Hospital Clínico Universitario de Valencia
Address:
City:
Valencia
Country:
Spain
Facility:
Name:
Hospital Universitario Miguel Servet
Address:
City:
Zaragoza
Country:
Spain
Facility:
Name:
Faculty of Medicine Siriraj Hospital
Address:
City:
Bang Phlat
Country:
Thailand
Facility:
Name:
Songklanagarind Hospital
Address:
City:
Hat Yai
Country:
Thailand
Facility:
Name:
Sunpasitthiprasong Hospital
Address:
City:
Ubon Ratchathani
Country:
Thailand
Facility:
Name:
T.C. Saglik Bakanligi Adana Sehir Egitim ve Arastirma Hastanesi
Address:
City:
Adana
Country:
Turkey
Facility:
Name:
Memorial Ankara Hastanesi
Address:
City:
Ankara
Country:
Turkey
Facility:
Name:
Kocaeli Üniversitesi Araştırma ve Uygulama Hastanesi
Address:
City:
Izmit
Country:
Turkey
Facility:
Name:
Inönü Üniversitesi Turgut Özal Tıp Merkezi
Address:
City:
Malatya
Country:
Turkey
Facility:
Name:
Ankara Üniversitesi Tıp Fakültesi - Cebeci Araştırma ve Uygulama Hastanesi
Address:
City:
Mamak
Country:
Turkey
Facility:
Name:
Van Yüzüncü Yıl Üniversitesi Dursun Odabaş Tıp Merkezi
Address:
City:
Van
Country:
Turkey
Facility:
Name:
Ataturk Universitesi Arastirma Hastanesi
Address:
City:
Yakutiye
Country:
Turkey
Facility:
Name:
Başkent Üniversitesi Adana Dr Turgut Noyan Uygulama ve Araştirma Merkezi
Address:
City:
Yüreğir
Country:
Turkey
Facility:
Name:
Barts Health NHS Trust
Address:
City:
London
Country:
United Kingdom
Facility:
Name:
Sarah Cannon Research Institute London
Address:
City:
London
Country:
United Kingdom
Facility:
Name:
The Royal Marsden NHS Foundation Trust
Address:
City:
London
Country:
United Kingdom
Facility:
Name:
University College London Hospitals NHS Foundation Trust
Address:
City:
London
Country:
United Kingdom
Facility:
Name:
The Christie NHS Foundation Trust
Address:
City:
Manchester
Country:
United Kingdom
Facility:
Name:
Oxford University Hospitals NHS Foundation Trust
Address:
City:
Oxford
Country:
United Kingdom
Facility:
Name:
The Royal Marsden NHS Foundation Trust
Address:
City:
Sutton
Country:
United Kingdom
Start date:
November 21, 2022
Completion date:
May 2026
Lead sponsor:
Agency:
Arcus Biosciences, Inc.
Agency class:
Industry
Collaborator:
Agency:
Gilead Sciences
Agency class:
Industry
Collaborator:
Agency:
Taiho Pharmaceutical Co., Ltd.
Agency class:
Industry
Source:
Arcus Biosciences, Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05568095